Teva launches generic GLP-1 in the US: Competition in the space is heating up. And with more generic drugs on the market, we think brand-name GLP-1 prices will be forced down.
Amazon Clinic gets rolled into One Medical: We explore what it means for Amazon’s broader healthcare strategy.
Medicare rebate program lowers prices on 64 prescription drugs: The Biden administration wants to improve its election odds by touting efforts that drive Rx savings for consumers.
Walgreens plans US store closures, reduces stake in VillageMD: It’s the latest domino to fall in the US’ embattled retail health space. We predict who could be next.
Patients aren’t sold on the safety of GLP-1s: It’s why most consumers prefer adopting healthy habits to taking medication for a health condition. We explore what this means for healthcare/pharma brands and marketers.
Kaiser Permanente-owned Risant Health to buy Cone Health: Here’s what the acquisition means for Risant’s value-based care ambitions in the not-for-profit provider space.
Medical/pharma TV ad impressions resonate most with older consumers: Our Industry KPI data should inform healthcare and pharma marketers’ strategies for targeting patients.
Eli Lilly goes after companies selling unauthorized GLP-1s: The chaotic state of the weight loss drug market is creating an opportunity for bad actors. Healthcare marketers will need to set the record straight.
Doctors’ list of burnout factors is getting longer: We dig into the key factors challenging physicians in their practices and examine how marketers and other providers could help offset them.
Medicare members can now use Amazon Pharmacy’s RxPass: But we don’t think this new offering will move the needle on prescription drug spending.
Surgeon General calls for social media warning labels: Here’s the data behind Dr. Vivek Murthy’s proposal and why steps like enforcing age appropriate standards are likely to effect real change sooner.
Color Health, OpenAI develop AI copilot: Here’s how the AI-powered cancer screening tool works and why OpenAI is continuing to push into healthcare.
Growing use of weight-loss drugs drives sales of smaller, more revealing clothing: Apparel retailers are expanding their size ranges and offering more risqué styles to accommodate shifting tastes.
Tobacco-like labels on social apps acould warn young people about potential harms, but any regulation would need congress approval which faces a block of lobyists.
Gen Zers and millennials are increasingly turning to social media platforms for health-related information. Here’s the data you need to ensure your marketing campaigns are reaching these cohorts.
Done CEO and head clinician charged with fraud in Adderall distribution scheme: Regulators are paying closer attention to companies that promote prescription drugs directly to consumers online. It’s a wake-up call for telehealth companies and healthcare marketers.
In TikTok we trust (for health): We unpack new survey results examining TikTok users’ trust in health content on the app and the opportunities this presents for healthcare marketers.
As more pharmacies shut down, where will consumers go? Some say that convenience matters more than brand loyalty, but just barely. Here’s how pharmacies can improve the patient experience as stores close across the US.
Michigan’s largest insurer to stop covering GLP-1s for obesity: Here are the details behind Blue Cross Blue Shield of Michigan’s decision and why estimates projecting skyrocketing GLP-1 uptake are likely overstated.
Users aren’t happy with the downgrades, and some may be wondering if it’s Google’s attempt to push them away from Fitbit and toward the Pixel Watch